A study was done by [17]	A study was done by [18]	A study was done by [19]	A study was done by [20]	A study was done by [21]	A study was done by [2]	A study was done by [22]	A study was done by [1]
Conclusion	Conclusion	Conclusion	Conclusion	Conclusion	Conclusion	Conclusion	Conclusion
These scientists realize that find proper pharmacologic method in inhibition cell lines can be a suitable objective in combat drug resistance in cancer	These researchers reach results that bypass cancer drug resistance pathways by necroptosis a good aim in the therapy of this disease	They can find combat with multi-drug resistance mechanisms in therapy cancer can be a challenging issue in the treatment of this fatal disease	These researchers in their findings study the genetic predisposition of patients in therapy cancer	They find in developed countries the use of standard cytotoxic chemotherapy can be a useful option in the therapeutic interval	They accentually point to inhibition resistance to chemotherapy and find molecular target therapy can be one important objective in therapy cancers	They reached the result that recognizing biological approaches is a suitable option for the treatment of drug resistance in cancer and should more studies be on this goal	Inhibition of Progenitor cells in treatment cancers is a very important aim for researchers because drug resistance in progression of these cells is a very important issue and finding treatment for these cells is a very key goal in therapy cancer
Limitation	Limitation	Limitation	Limitation	Limitation	Limitation	Limitation	Limitation
In this predisposition should do more research about enhance efficacy and anti-cancer properties for drug resistance in the treatment of cancer	Scientists find that until now there aren’t a few versatile pathways for bypass drug resistance in cancer via necroptosis this option needs more understanding and realize	Studies about resolving MDR in cancer therapy have had very little to do until now and should be done in vivo and in vitro studies for the therapy of this disease	These researchers should do more studies on the inhibition of methylation, acetylation, apoptosis, or genetic heterogeneity which can be an obstacle to therapy of 90% of patients in the world	Scientists in the oncology domain should focus on enhanced knowledge and technology in the use of in vitro experiments to reach this sensitive topic of research	Researchers should understand the mechanisms of drug resistance in biology or physics mechanisms that need more study and research	Studies about this subject are a very high fee that very of researchers cannot do these works and should combat this issue	Studies about this factor are very limited and need to evaluate research on this subject

Table 1: Studies done by researchers about drug resistance in evaluating cancer